生物工艺优化客户协作实验室
在M Lab™协作中心了解、优化和放大您的生物工艺
每一次M Lab™ 协作中心经历都为满足您的独特需求量身定制。
- 在多模式、非GMP环境探索新技术。在不中断自身运营的情况下开发和优化您的整个生物制药工艺流程。
- 了解Bioprocessing 4.0 如何加快您的上市速度。通过自动化工作流程、AI软件进行实验，预测工艺参数并进行其他前沿创新。
- 与 300 多位科学领袖协作。无论您的治疗制剂属于哪种类型，总能在此找到合适的专家帮助解决上下游挑战。
在整个工艺流程中利用动态技术经验提升您的生物工艺团队技能。
生物制造/制药制造技术和法规不断发展。想要立于不败之地，您的团队也要与时俱进。
为此，我们在 北美和全球提供了大量此类生物制造培训机会。平均 20 年经验的技术培训师将通过各种交付平台助您的团队成长并增强上下游技能：
- 面对面 →在您的设施或 M Lab™ 协作中心进行实操生物生产培训
- 直播 →从我们的实验室向您提供交互式学习体验
- 在线学习 → 随时随地数字化点播
将您的想法付诸实践（同时又避免您的生物工艺操作陷入风险）
无论您是要开发新分子还是重购既定的生产策略，M Lab™ 协作中心提供的灵活的空间都可在您付诸实施之前，激发您对新的生物制药制造工艺的求知欲、掌握操作规程，并在际生产之前优化您的放大方法。
为生物技术初创公司提供未来保障
由熟谙先驱者成功要素的专家提供个性化支持，避免在商业化道路上踩坑。M Lab™ 协作中心利用我们的生物技术资源中心为您提供完整的解决方案。
随时随地针对任何问题设计生物工艺解决方案
访问就近的全球生物技术中心 M Lab™ 协作中心，或通过无缝的全球领先远程技术虚拟协作。
相关资源
- Brochure: M Lab™ Collaboration Center
A global network of vibrant collaboration labs where Life Science innovators explore big ideas, learn new techniques, and rapidly move from complex problems to optimal solutions–together.
- Podcast: Collaborations in Bioprocessing
In the podcasts below, you can listen to compelling stories of novel solutions and innovative application of technologies that brought M Lab™ Collaboration Centers team members together with various biopharmacuetical manufacturers to make science, better.
- Educational Brochure: Biopharmaceutical Course Brochure
Enhance your skill set by taking practical, hands-on bioprocessing and formulation courses at our M Lab™ Collaboration Centers, or invite our trainers to your site.
- Flyer: Collaborate for Success in Pharmaceutical Manufacturing
With the M Lab™ Collaboration Centers’ flexible, non-GMP environment and global network of technical expertise, you can solve your toughest problems, from adoption of single-use technologies to virus detection and removal, and expansion in emerging markets.
- Article: Tapping into Collective Intelligence: Why Collaboration is Critical for the Adoption and Implementation of Next-generation Bioprocessing
Next-generation bioprocessing is a step-by-step evolution already well underway as the pharma industry undergoes a paradigm shift toward continuous processing.
- Report: Biopharma's Evolution: Learnings from the Pandemic for a Revived Regulatory Landscape
It took seven months from clinical trials commencing for the first covid-19 vaccine to be made available for public use. Pre-pandemic, the median time to market for a biotherapeutic treatment was nine years and four months, and the fastest had been four years for mumps in the 1960s.
相关视频
如要继续阅读，请登录或创建帐户。
暂无帐户？